iTeos Therapeutics, Inc. (ITOS)
USD 7.26
(-5.59%)
USD 7.26
(-5.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.59 Million | 267.63 Million | 344.77 Million | - | - | - |
| Cost of Revenue | 898 Thousand | 813 Thousand | 615 Thousand | 535 Thousand | 611 Thousand | 505 Thousand |
| Gross Profit | 11.69 Million | 266.81 Million | 344.16 Million | -535 Thousand | -611 Thousand | -505 Thousand |
| Operating Expenses | 163.69 Million | 138.04 Million | 89.69 Million | 39.3 Million | 23.26 Million | 17.81 Million |
| Selling, General and Administrative Expenses | 50.39 Million | 43.94 Million | 40.5 Million | 15.34 Million | 8.83 Million | 4.31 Million |
| Research and Development Expenses | 113.3 Million | 97.35 Million | 59.36 Million | 29.9 Million | 19.21 Million | 17.18 Million |
| Other Expenses | - | -3.26 Million | -10.18 Million | -5.93 Million | -4.77 Million | -163 Thousand |
| Cost and Expenses | 163.69 Million | 138.04 Million | 89.69 Million | 39.3 Million | 23.26 Million | 17.81 Million |
| Operating Income | -151.1 Million | 126.32 Million | 244.9 Million | -45.24 Million | -28.04 Million | -21.5 Million |
| Interest Expense | - | - | - | - | - | 66 Thousand |
| Income Tax Expense | 3.61 Million | 52.08 Million | 41.94 Million | -57 Thousand | 119 Thousand | 11 Thousand |
| Earnings before Tax | -109.03 Million | 148.73 Million | 256.46 Million | -38.09 Million | -22.33 Million | -18.04 Million |
| Net Income | -112.64 Million | 96.65 Million | 214.52 Million | -38.03 Million | -22.45 Million | -18.05 Million |
| Earnings Per Share Basic | -3.15 | 2.72 | 6.10 | -1.09 | -0.64 | -2.40 |
| Earnings Per Share Diluted | -3.15 | 2.56 | 5.68 | -1.09 | -0.64 | -2.40 |
| Weighted Average Shares Outstanding | 35.76 Million | 35.55 Million | 35.18 Million | 35.04 Million | 35.02 Million | 7.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.76 Million | 37.76 Million | 37.77 Million | 35.04 Million | 35.02 Million | 7.51 Million |
| Gross Margin | 0.93 | 1.00 | 1.00 | - | - | - |
| EBIT Margin | -12.00 | 0.49 | 0.74 | - | - | - |
| Profit Margin | -8.94 | 0.36 | 0.62 | - | - | - |
| EBITDA | -151.1 Million | 148.37 Million | 257.07 Million | -37.84 Million | -21.72 Million | -17.47 Million |
| Earnings Before Tax Margin | -12.00 | 0.47 | 0.71 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 35 Million | - | 12.59 Million | -11.3 Million | - | - |
| Cost of Revenue | 309 Thousand | 303 Thousand | 898 Thousand | 233 Thousand | 224 Thousand | 198 Thousand |
| Gross Profit | 34.69 Million | -303 Thousand | 11.69 Million | -11.53 Million | -224 Thousand | -198 Thousand |
| Operating Expenses | 48.85 Million | 46.92 Million | 157.48 Million | 37.24 Million | 42.23 Million | 41.43 Million |
| Selling, General and Administrative Expenses | 12.45 Million | 12.7 Million | - | 12.36 Million | 12.64 Million | 13.43 Million |
| Research and Development Expenses | 36.4 Million | 34.22 Million | - | 27.77 Million | 30.63 Million | 29.18 Million |
| Other Expenses | 67 Thousand | 2.09 Million | 4.08 Million | 1.21 Million | 771 Thousand | 326 Thousand |
| Cost and Expenses | 49.16 Million | 47.23 Million | 157.48 Million | 37.24 Million | 42.23 Million | 41.43 Million |
| Operating Income | -14.16 Million | -47.23 Million | -151.1 Million | -40.14 Million | -43.28 Million | -42.62 Million |
| Interest Expense | - | - | - | 8.18 Million | - | - |
| Income Tax Expense | 1.36 Million | 1.41 Million | 3.61 Million | 2.36 Million | -1.18 Million | 1.23 Million |
| Earnings before Tax | -5.76 Million | -36.8 Million | -109.03 Million | -28.18 Million | -33.42 Million | -33.06 Million |
| Net Income | -7.12 Million | -38.21 Million | -112.64 Million | -30.55 Million | -32.24 Million | -34.3 Million |
| Earnings Per Share Basic | -0.18 | -1.07 | - | -0.85 | -0.90 | -0.96 |
| Earnings Per Share Diluted | -0.18 | -1.07 | - | -0.85 | -0.90 | -0.96 |
| Weighted Average Shares Outstanding | 39.69 Million | 35.84 Million | 35.76 Million | 35.83 Million | 35.78 Million | 35.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.69 Million | 35.84 Million | 35.76 Million | 35.83 Million | 35.78 Million | 35.76 Million |
| Gross Margin | 0.99 | - | 0.93 | 1.02 | - | - |
| EBIT Margin | -0.40 | - | - | 3.27 | - | - |
| Profit Margin | -0.20 | - | -8.94 | 2.70 | - | - |
| EBITDA | -13.85 Million | -46.92 Million | - | -37.01 Million | -42 Million | -41.21 Million |
| Earnings Before Tax Margin | -0.40 | - | -12.00 | 3.55 | - | - |
CRR-UN
FRLOF
SHL
3DA
AGY
UTRX